| Target Price | $816.00 |
| Price | $551.79 |
| Potential | 47.88% |
| Number of Estimates | 21 |
| 21 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $816.00. This is 47.88% higher than the current stock price. The highest price target is $971.25 76.02% , the lowest is $616.10 11.65% . | |
| A rating was issued by 28 analysts: 25 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 47.88% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
24 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.8b . This is 9.19% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.9b 12.82% , the lowest is $2.7b 4.77% .
This results in the following potential growth metrics:
| 2024 | $2.1b | 33.44% |
|---|---|---|
| 2025 | $2.8b | 34.12% |
| 2026 | $3.5b | 25.56% |
| 2027 | $4.3b | 24.01% |
22 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $698m . This is 3,883.39% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $724m 4,034.99% , the lowest is $663m 3,686.87% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $112m | 41.87% |
|---|---|---|
| 2025 | $698m | 524.96% |
| 2026 | $887m | 27.03% |
| 2027 | $1.1b | 29.50% |
| 2024 | 5.36% | 56.43% |
|---|---|---|
| 2025 | 24.99% | 366.04% |
| 2026 | 25.28% | 1.16% |
| 2027 | 26.40% | 4.43% |
23 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $506m . This is 96.91% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $564m 119.29% , the lowest is $467m 81.63% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $377m | 114.49% |
|---|---|---|
| 2025 | $506m | 34.27% |
| 2026 | $608m | 20.10% |
| 2027 | $767m | 26.14% |
| 2024 | 18.10% | 60.74% |
|---|---|---|
| 2025 | 18.13% | 0.14% |
| 2026 | 17.34% | 4.36% |
| 2027 | 17.64% | 1.73% |
23 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.45 . This is 97.25% higher than earnings per share in the financial year 2024. The highest EPS forecast is $7.18 119.57% , the lowest is $5.95 81.96% .
This results in the following potential growth metrics and future valuations:
| 2024 | $4.80 | 106.01% |
|---|---|---|
| 2025 | $6.45 | 34.38% |
| 2026 | $7.75 | 20.16% |
| 2027 | $9.77 | 26.06% |
| Current | 168.74 | 44.69% |
|---|---|---|
| 2025 | 85.56 | 49.30% |
| 2026 | 71.24 | 16.74% |
| 2027 | 56.48 | 20.72% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 15.43 and an P/S ratio of 15.59 .
This results in the following potential growth metrics and future valuations:
| Current | 16.85 | 16.95% |
|---|---|---|
| 2025 | 15.43 | 8.41% |
| 2026 | 12.29 | 20.36% |
| 2027 | 9.91 | 19.36% |
| Current | 17.02 | 16.92% |
|---|---|---|
| 2025 | 15.59 | 8.42% |
| 2026 | 12.42 | 20.36% |
| 2027 | 10.01 | 19.36% |
Axon Enterprise Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
➜
Outperform
|
Initiated | Nov 17 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Nov 06 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Nov 05 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 05 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Nov 05 2025 |
| JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Sep 29 2025 |
| Piper Sandler |
➜
Overweight
|
Initiated | Sep 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Initiated
RBC Capital:
➜
Outperform
|
Nov 17 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Nov 06 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Nov 05 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 05 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Nov 05 2025 |
|
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Sep 29 2025 |
|
Initiated
Piper Sandler:
➜
Overweight
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


